You probably know someone who has it. It is the most common movement disorder, yet most people don’t even know its name. Essential tremor affects nearly one per cent of the world’s population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.
The Montreal Neurological Institute and Hospital (The Neuro) is pleased to announce the launch of a new clinical program designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care. The Susan Cameron Cook Neuro-Palliative Care Program, named in honour of Susan Cameron Cook, whose family provided vital seed funding for the program, has been designed with the goal of reducing the mental and physical suffering of neurological patients and their families in the journey from diagnosis of a terminal illness to end of life.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at McGill University and the McGill University Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, Médecins francophones du Canada, is bestowing on him its 2016 Prix de l’oeuvre scientifique.
Inspiring event to raise money for brain cancer research An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.
KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC
KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer’s treatment in Canada that the parties have been co- developing since 2015. The treatment, a biologic molecule made up of a peptide that fights Alzheimer’s and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis. The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
The Neuro’s director, Dr. Guy Rouleau, has received yet another honour in recognition of his sterling scientific career. The Royal Society of Canada (RSC) announced on Sept. 7 that its members had elected Dr. Rouleau as one of its new Fellows. He joins a currently active membership of more than 2,000 highly distinguished scientists, scholars and artists who nominate and elect up to 75 new members each year.
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.
Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
We are fortunate to welcome Dr. Boris Bernhardt as BIC core Faculty Member as of August 1, 2016. Boris is a new Assistant Professor in the Department of Neurology and Neurosurgery at McGill and a member of the Epilepsy research group at the MNI. He obtained his PhD in Neuroscience at McGill in 2011 and carried out postdoctoral studies at the Max-Planck Institute for Cognitive and Brain Sciences in Leipzig, Germany. Boris heads the newly-founded Multimodal Imaging and Connectome Analysis Lab at the BIC.
3D depth-sensing camera shown to measure walking difficulties A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients. The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
Research underlines importance of computational power in future neurological breakthrough Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease. Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.
Two exciting core staff job opportunities at the McConnell Brain Imaging Centre/Montreal Neurological Institute (McGill, Montreal): 1 Scientific Developer/Application Specialist (MEG & EEG) 1 Manager, Data Resources Full job descriptions and details on how to apply. Looking forward to hiring new talents, with the strongest motivation to work and make a difference in an open, collaborative and multidisciplinary environment.
The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.